Loading...
  • Patients
  • During Ramadan, patients treated with Victoza(R) experienced fewer confirmed hypoglycaemic episodes compared with people treated with sulfonylurea (2.0% vs. 4.3%), even though the Victoza(R) group had lower fructosamine concentration at the start of Ramadan. (europapress.es)
  • RESEARCH DESIGN AND METHODS We abstracted depression and severe dysglycemia requiring emergency room visit or hospitalization from medical health records in 3,742 patients with T1D during the study period (1996-2015). (diabetesjournals.org)
  • CONCLUSIONS Depression and severe dysglycemia are associated bidirectionally among patients with T1D. (diabetesjournals.org)
  • Hypoglycemia Patients and Transport by EMS in Alameda County, 2013-15. (yale.edu)
  • During the 180 days, 38 percent of patients treated with insulin had low blood sugar, 18 percent had severe low blood sugar and 35 percent had high blood sugar. (drugs.com)
  • Those institutions often "export guidelines for hospitalized patients, and end up continuing to use a lot of medications that cause hypoglycemia," he said. (drugs.com)
  • A large randomized trial in patients with type 1 diabetes with nocturnal hypoglycemia reported that sensor-augmented insulin pump therapy with the threshold suspend feature reduced nocturnal hypoglycemia, without increasing glycated hemoglobin values ( 3 ). (diabetesjournals.org)
  • For most patients (especially those at elevated risk of hypoglycemia), use insulin analogs. (diabetesjournals.org)
  • include
  • Risks associated with use of the system may include hypoglycemia, hyperglycemia, as well as skin irritation or redness around the device's infusion patch. (fda.gov)
  • On the other hand, the disadvantages identified include the need for training and support to use this technology, the costs, the discomfort of wearing the pump, the fear of hypoglycemia and a risk of device failure. (type1better.com)
  • dose
  • All subjects avoided severe hypoglycemia by significantly reducing their insulin dose and consuming additional carbohydrates. (nih.gov)
  • Most people with type 1 diabetes should be treated with multiple-dose insulin injections (three to four injections per day of basal and prandial insulin) or continuous subcutaneous insulin infusion. (diabetesjournals.org)
  • Although most studies of multiple-dose insulin versus pump therapy have been small and of short duration, a systematic review and meta-analysis concluded that there are minimal differences between the two forms of intensive insulin therapy in A1C (combined mean between-group difference favoring insulin pump therapy −0.30% [95% CI −0.58 to −0. and severe hypoglycemia rates in children and adults ( 2 ). (diabetesjournals.org)
  • DKA occurs mainly in people with type 1 diabetes, and can be triggered by having an infection or other illness or not taking your usual dose(s) of insulin. (mydr.com.au)
  • significantly
  • People treated with Victoza(R) also demonstrated significantly better weight loss and fewer confirmed hypoglycaemic episodes compared with those treated with sulfonylurea during Ramadan. (europapress.es)
  • hypoglycaemic
  • This is a change in the law from the previous requirement to cease driving if a person had two or more severe hypoglycaemic attacks in a year, even if they were asleep when one of the episodes took place. (thegoodhealthsuite.co.uk)
  • Hypoglycaemia can be the result of taking too much insulin or oral hypoglycaemic medicines, not eating enough carbohydrates, drinking alcohol or exercising excessively or for a prolonged period. (mydr.com.au)
  • clinical
  • The study was a 33-week, open-label, multinational clinical trial involving 343 people (172 for Victoza(R), 171 for sulfonylurea). (europapress.es)
  • As Medtronic continues to expand into providing more solutions for people living with type 2 as well as type 1 diabetes, collaborating with the world`s experts to build a clinical body of evidence to help guide therapy for all people with diabetes is very important," said Francine R. Kaufman, M.D., chief medical officer and vice president of global, clinical and medical affairs for Medtronic Diabetes. (yahoo.com)
  • This clinical trial showed that the device is safe for use in people 14 years of age and older with type 1 diabetes. (fda.gov)
  • Diabetes Care
  • As part of our commitment to improving diabetes care, the FDA worked interactively with Medtronic from the earliest stages of development to assist in making this technology available to people with type 1 diabetes as quickly as possible," said Alberto Gutierrez, Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health in the FDA's Center for Devices and Radiological Health. (fda.gov)
  • THURSDAY, Jan. 4, 2018 -- Decisions about diabetes care can become harder as people age, and that may be especially true for those needing hospice care. (drugs.com)
  • A new study has found that, among people getting hospice care in a nursing home, diabetes care may lead to higher rates of dangerous low blood sugar episodes, known as hypoglycemia. (drugs.com)
  • addition
  • In addition, the rules for operating a commercial motor vehicle, and for obtaining related license endorsements (such as rules restricting operation of a school bus or transport of passengers or hazardous materials) are quite different and in many ways more cumbersome for people with diabetes, especially those who use insulin. (diabetesjournals.org)
  • In addition, "the new regulations will also mean that people who lose their licence after having severe episodes of hypoglycaemia will be able to renew their licence within three months of their last episode. (thegoodhealthsuite.co.uk)
  • Byetta
  • And too new to be included are Symlin and Byetta, which some people do consider to be breakthrough drugs, but might well fall out according to the book's seven-year rule. (healthcentral.com)